Eli Lilly and Company vs AbbVie Inc. Stock Comparison
Side-by-side stock comparison - today's price, recent moves, technicals, and why each moved. Educational data, not a recommendation.
Side-by-side stock comparison - today's price, recent moves, technicals, and why each moved. Educational data, not a recommendation.
Eli Lilly and Company (LLY) is up 1.26% while AbbVie Inc. (ABBV) is up 0.20% on the NYSE/NASDAQ. Today, Eli Lilly and Company has the larger percentage move. Over the last 5 trading sessions, Eli Lilly and Company is up 4.56% and AbbVie Inc. is up 1.73%. Over about 6 months, Eli Lilly and Company is up 43.39% and AbbVie Inc. is up 39.98%.
Move strength and explanation confidence are TechTars scores built from price, volume, news, sector and technical data. How they are calculated.
There is no single answer, and TechTars does not recommend either stock. Which one suits you depends on your goals, time horizon and how much risk you can take. Here is how Eli Lilly and Company and AbbVie Inc. compare on the facts.
Past moves do not predict future returns. A bigger typical daily move means larger swings in both directions.
LLY rose 1.3% after the headline "Lilly to present new data across Zepbound, Foundayo, EloraTZP and...".
ABBV rose 0.2% after the headline "How Retirees Can Turn $175,000 Into Passive Income With These 4...".
TechTars does not say which stock to buy. The answer depends on your goals, time horizon and risk tolerance. Over the last 5 trading sessions, Eli Lilly and Company is up 4.56% and AbbVie Inc. is up 1.73%. Over about 6 months, Eli Lilly and Company is up 43.39% and AbbVie Inc. is up 39.98%. Past moves do not predict future returns. Read the full analysis of each stock, and speak to a registered investment adviser before investing.
On a typical day over the past 6 months, Eli Lilly and Company moved about 1.52% and AbbVie Inc. about 1.17%, so Eli Lilly and Company has had the bigger daily swings. A bigger typical daily move means larger swings in both directions.
Eli Lilly and Company is 1.1% below its 52-week high and AbbVie Inc. is 2.6% below its own. The 52-week high is the highest price in the past year.